Delivery Order SPE2DB22D6029-SPE2DB24FLTCM
Award Date
9/10/24
Potential Completion Date
9/11/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,157.14 firm fixed-price delivery order is for the supply of 4 mg/20 ml vials of the medication glycopyrrolate. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies supporting...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,377.50 Firm Fixed Price delivery order is for the supply of GLYCOPYRROLATE INJECT, a medication used to treat certain conditions. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen, through its Corporate Office division, is the prime contractor and there is no set-aside designation. This award...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,050.14, is for the delivery of 4 mg/20 ml vials of the medication glycopyrrolate. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA,...
This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,341.26, is for the supply of glycopyrrolate 0.2 mg/ml vials (20 ml) to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of May 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
The U.S. federal government, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of pharmaceuticals, specifically the drug glycopyrrolate 1 mg/5 ml vial 5 ml, with a ceiling value of $1,524.65. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of glycopyrrolate 0.2 mg/ml vial, 2 ml, a medication used to treat certain medical conditions. The contract has a ceiling value of $4,591.37 and a completion date of July 22, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, valued at $1,377.50. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is for the delivery of GLYCOPYRROLATE INJECT, a pharmaceutical product. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,663.89, is for the delivery of 4563500485 - GLYCOPYRROLATE 2ML 25S, a pharmaceutical product. The award has an ultimate completion date of February 28, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,401.83, is for the delivery of GLYCOPYRROLATE INJECT, a pharmaceutical product, to support military healthcare programs and facilities. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 27, 2024. This award is not associated with any...
This is a federal contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.2 mg/ml glycopyrrolate vial with a 2 ml volume. The contract has a ceiling value of $16,735.09 and is a firm fixed price delivery order. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...